⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23018232 | 1.00 | — | — | |
| SCHEMBL2897023 | 1.00 | — | — | |
| SCHEMBL15909334 | 1.00 | — | — | |
| SCHEMBL23564432 | 1.00 | — | — | |
| SCHEMBL1569653 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2925918 | 0.98 | AGL (0.41) | — | |
| Hydrochloric Acid SCHEMBL2925474 | 0.98 | AGL (0.41) | — | |
| Hydrochloric Acid SCHEMBL2925479 | 0.98 | AGL (0.41) | — | |
| Hydrochloric Acid SCHEMBL2925920 | 0.98 | AGL (0.41) | — | |
| Hydrochloric Acid SCHEMBL2925477 | 0.98 | AGL (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250250287-A1 | HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | BEIGENE SWITZERLAND GMBH (CH) | 2025-08-07 | — | — | US | disclosed |
| EP-4568973-A1 | HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | BeiGene Switzerland GmbH (CH) | 2025-06-18 | — | — | EP | disclosed |
| CN-119654327-A | Heterocyclic compounds, compositions thereof and methods of treatment thereof | 百济神州(苏州)生物科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024032703-A1 | HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | BEIGENE, LTD. (KY) | 2024-02-15 | — | — | WO | disclosed |
| EP-3461812-B1 | N-(5-(BIPHEN-4-YLMETHYLOXY)PENTYL)-SUBSTITUTED IMINOSUGARS AS INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE | ACAD MEDISCH CT (NL) | 2021-10-13 | — | — | EP | disclosed |
| EP-3782655-A1 | A METHOD FOR THE TREATMENT OF POMPE DISEASE USING 1-DEOXYNOJIRIMYCIN AND DERIVATIVES | Amicus Therapeutics, Inc. (US) | 2021-02-24 | — | — | EP | disclosed |
| EP-3215499-B1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | EMERGENT VIROLOGY LLC (US) | 2021-01-20 | — | — | EP | disclosed |
| EP-3461812-A1 | N-(5-(BIPHEN-4-YLMETHYLOXY)PENTYL)-SUBSTITUTED IMINOSUGARS AS INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE | Academisch Medisch Centrum (NL) | 2019-04-03 | — | — | EP | disclosed |
| EP-3441090-A1 | A METHOD FOR THE TREATMENT OF POMPE DISEASE USING 1-DEOXYNOJIRIMYCIN AND DERIVATIVES | Amicus Therapeutics, Inc. (US) | 2019-02-13 | — | — | EP | disclosed |
| WO-2018100386-A1 | METHODS AND COMPOSITIONS FOR IMPROVING FEED OUTCOMES | BANGOR UNIVERSITY (GB) | 2018-06-07 | — | — | WO | disclosed |
| US-8796256-B2 | Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators | JANSSEN PHARMACEUTICA NV (BE) | 2014-08-05 | — | — | US | disclosed |
| US-20110294780-A1 | SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-12-01 | — | — | US | disclosed |
| EP-2010506-B1 | DIAZEPAN DERIVATIVES MODULATORS OF CHEMOKINE RECEPTORS | HOFFMANN LA ROCHE (CH) | 2010-08-04 | — | — | EP | disclosed |
| WO-2009114679-A2 | TREATMENT OF POMPE DISEASE WITH SPECIFIC PHARMACOLOGICAL CHAPERONES AND MONITORING TREATMENT USING SURROGATE MARKERS | AMICUS THERAPEUTICS, INC (US) | 2009-09-17 | — | — | WO | disclosed |